PCVX

NASDAQVaxcyte Inc
High Tide · 60Squeeze · Watch 40Bullish0 buys · -$376KSocial · No data 0
$59.51
$-0.85 (-1.41%)
15-min delayed · Sep 10, 3:17 AMReal-time

Score summary

Buy
Analyst Ratings
3Ratings
2 Buy1 Hold0 Sell
Tide Score
60
High Tide · stable · Top 24% of universe (3998)
Outlook46Calm Tide · stable · Bottom 36% of universe (3999)
Squeeze Score
40
Watch ·
  • Days to cover15.85
  • Short interest10.84% of float
  • Borrow rate33.39%
  • Short interest trend+0.23% (30d)
Trend
Bullish
Trending up — 4 of 8 indicators bullish
Recent Smart Money
0 buys
Quiet · -$376k · 14d · 7 super investors

Key statistics

Market Cap
$9.10B
52-week range
$30.89 – $63.30
93% from low
Day range
$59 – $60
Open $59.99
Volume
1.2M
vs 980k avg · 122%
P/E (TTM)
Fwd —
Earnings
Nov 3
54d · est $-1.84

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 3 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$89
3 Wall St 12-month targets
High
$116
Average
$81
Low
$38
$35$56$77$98$119HIGH$116MEDIAN$89LOW$38Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 67/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Nov 3 (post-market, est EPS $-1.84) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.